Literature DB >> 8224916

Sequence and organization of the human N-formyl peptide receptor-encoding gene.

P M Murphy1, H L Tiffany, D McDermott, S K Ahuja.   

Abstract

The human FPR1 gene encodes the N-formyl peptide receptor, a G protein-coupled receptor (GPCR) that mediates the activation of mature myeloid cells by bacterial N-formyl oligopeptides. To investigate the molecular basis for myeloid-specific production of this receptor, we have cloned and sequenced FPR1. The gene is organized into three exons and two introns that span 6 kb. The coding block lacks introns. Yet, the transcription start point (tsp) is separated from the start codon by 4902 bp consisting of three exons and two large introns. Two mRNAs are produced by alternative splicing of exon 2 in HL-60 neutrophils and normal blood monocytes. The region 5' to the tsp contains three pyrimidine-rich segments, a feature that has been observed in other myeloid-specific genes. One complete Alu repeat is found in each intron and in the 3'-flanking region 317 bp downstream of the polyadenylation signal. Thus, FPR1 is a small myeloid-specific gene that is expressed as two alternatively spliced mRNAs encoding the same protein.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8224916     DOI: 10.1016/0378-1119(93)90653-k

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  10 in total

1.  Functional differences between human formyl peptide receptor isoforms 26, 98, and G6.

Authors:  Katharina Wenzel-Seifert; Roland Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-04-05       Impact factor: 3.000

2.  Genetic alterations of RD(INK4/ARF) enhancer in human cancer cells.

Authors:  Junan Li; Thomas J Knobloch; Ming J Poi; Zhaoxia Zhang; Andrew T Davis; Peter Muscarella; Christopher M Weghorst
Journal:  Mol Carcinog       Date:  2012-10-12       Impact factor: 4.784

3.  Molecular evolution of the N-formyl peptide and C5a receptors in non-human primates.

Authors:  V Alvarez; E Coto; F Setién; S González-Roces; C López-Larrea
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

4.  Subinhibitory concentrations of the deformylase inhibitor actinonin increase bacterial release of neutrophil-activating peptides: a new approach to antimicrobial chemotherapy.

Authors:  Huamei Fu; Claes Dahlgren; Johan Bylund
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

5.  Regulation of human formyl peptide receptor 1 synthesis: role of single nucleotide polymorphisms, transcription factors, and inflammatory mediators.

Authors:  Heini M Miettinen
Journal:  PLoS One       Date:  2011-12-09       Impact factor: 3.240

6.  Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils.

Authors:  P D Ponath; S Qin; T W Post; J Wang; L Wu; N P Gerard; W Newman; C Gerard; C R Mackay
Journal:  J Exp Med       Date:  1996-06-01       Impact factor: 14.307

7.  Identification of Novel Signal Transduction, Immune Function, and Oxidative Stress Genes and Pathways by Topiramate for Treatment of Methamphetamine Dependence Based on Secondary Outcomes.

Authors:  Tianhua Niu; Jingjing Li; Ju Wang; Jennie Z Ma; Ming D Li
Journal:  Front Psychiatry       Date:  2017-12-13       Impact factor: 4.157

8.  Targeting Endothelial Barrier Dysfunction Caused by Circulating Bacterial and Mitochondrial N-Formyl Peptides With Deformylase.

Authors:  Patricia Martinez-Quinones; Amel Komic; Cameron G McCarthy; R Clinton Webb; Camilla Ferreira Wenceslau
Journal:  Front Immunol       Date:  2019-06-06       Impact factor: 7.561

9.  Defining Molecular Treatment Targets for Bladder Pain Syndrome/Interstitial Cystitis: Uncovering Adhesion Molecules.

Authors:  Guldal Inal-Gultekin; Zeliha Gormez; Naside Mangir
Journal:  Front Pharmacol       Date:  2022-03-25       Impact factor: 5.810

10.  Parallel affinity-based isolation of leukocyte subsets using microfluidics: application for stroke diagnosis.

Authors:  Swathi R Pullagurla; Małgorzata A Witek; Joshua M Jackson; Maria A M Lindell; Mateusz L Hupert; Irina V Nesterova; Alison E Baird; Steven A Soper
Journal:  Anal Chem       Date:  2014-04-01       Impact factor: 6.986

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.